These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32584606)

  • 21. Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.
    Watanabe T; Minezawa T; Hasegawa M; Goto Y; Okamura T; Sakakibara Y; Niwa Y; Kato A; Hayashi M; Isogai S; Kondo M; Yamamoto N; Hashimoto N; Imaizumi K
    BMC Pulm Med; 2019 Nov; 19(1):194. PubMed ID: 31675941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases.
    Si-Mohamed SA; Nasser M; Colevray M; Nempont O; Lartaud PJ; Vlachomitrou A; Broussaud T; Ahmad K; Traclet J; Cottin V; Boussel L
    Eur Radiol; 2022 Jun; 32(6):4292-4303. PubMed ID: 35029730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior.
    Khine N; Mudawi D; Rivera-Ortega P; Leonard C; Chaudhuri N; Margaritopoulos GA
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):231-233. PubMed ID: 33093788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clubbing in patients with fibrotic interstitial lung diseases.
    van Manen MJG; Vermeer LC; Moor CC; Vrijenhoeff R; Grutters JC; Veltkamp M; Wijsenbeek MS
    Respir Med; 2017 Nov; 132():226-231. PubMed ID: 29229102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.
    Raghu G; Mageto YN; Lockhart D; Schmidt RA; Wood DE; Godwin JD
    Chest; 1999 Nov; 116(5):1168-74. PubMed ID: 10559072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease.
    Hoffmann-Vold AM; Weigt SS; Saggar R; Palchevskiy V; Volkmann ER; Liang LL; Ross D; Ardehali A; Lynch JP; Belperio JA
    EBioMedicine; 2019 Dec; 50():379-386. PubMed ID: 31732480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
    Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
    Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging biomarkers of lung ventilation in interstitial lung disease from
    Tibiletti M; Eaden JA; Naish JH; Hughes PJC; Waterton JC; Heaton MJ; Chaudhuri N; Skeoch S; Bruce IN; Bianchi S; Wild JM; Parker GJM
    Magn Reson Imaging; 2023 Jan; 95():39-49. PubMed ID: 36252693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
    Callahan SJ; Xia M; Murray S; Flaherty KR
    Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF).
    Enomoto N; Kusagaya H; Oyama Y; Kono M; Kaida Y; Kuroishi S; Hashimoto D; Fujisawa T; Yokomura K; Inui N; Nakamura Y; Suda T
    BMC Pulm Med; 2014 May; 14():91. PubMed ID: 24886550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact of the radiological indeterminate for usual interstitial pneumonia pattern on the diagnosis of idiopathic pulmonary fibrosis.
    Inomata M; Jo T; Kuse N; Awano N; Tone M; Yoshimura H; Moriya A; Bae Y; Terada Y; Furuhata Y; Kumasaka T; Ushiwata A; Harada A; Terasaki Y; Takeuchi M; Sugiura H; Takemura T; Izumo T
    Respir Investig; 2021 Jan; 59(1):81-89. PubMed ID: 32868263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease.
    Gibson CD; Kugler MC; Deshwal H; Munger JS; Condos R
    Lung; 2020 Aug; 198(4):597-608. PubMed ID: 32591895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse Pulmonary Ossification in Fibrosing Interstitial Lung Diseases: Prevalence and Associations.
    Egashira R; Jacob J; Kokosi MA; Brun AL; Rice A; Nicholson AG; Wells AU; Hansell DM
    Radiology; 2017 Jul; 284(1):255-263. PubMed ID: 28182861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.